Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Jnana Therapeutics Inc.

Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases, immune-mediated diseases and cancer. Jnana’s wholly owned lead program is a potential first-in-class oral approach, targeting an allosteric site on the phenylalanine transporter SLC6A19, for the treatment of phenylketonuria (PKU), a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, a highly experienced management team and the backing of leading life science investors Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures and AbbVie Ventures. *

 

Period Start 2017-12-14 established
Products Industry drug discovery
  Industry 2 small-molecule drug
Persons Person Kotz, Joanne (Jnana Therapeutics 202108 CEO + Co-Founder)
  Person 2 Nashat, Amir (Poralis Partners 201712 Managing Partner + 201712 CEO at Jnana Therapeutics)
     
Region Region Boston, MA
  Country United States (USA)
  Street 6 Tide Street
  City 02210 Boston, MA
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA.
     
   
Record changed: 2023-07-10

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Jnana Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px




» top